MSH2 and colorectal carcinoma: We investigated BRCA1/2 mutations in the MSH2/MLH1-mutant (MSI-H) and the non-MSI-H CRC patient sample groups to decipher the statistical, structural, and functional difference in BRCA mutations of each group.